| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Sep 17, 2020 |
|||||||||
|
Apogee Enterprises
APOG
|
Q2 FY21 | $0.73 | $0.30 | $319.48M | $131.29M |
NASDAQ |
|||
|
Perspective Therapeutics
CATX
|
Q4 FY20 | -$0.02 | -$0.01 | $2.28M | $1.14M |
AMEX |
|||
|
Dyne Therapeutics
DYN
|
- | -$0.62 | - | - | - |
NASDAQ |
|||
Showing
1
to
3
of
3 entries